CYSLTR1 and cancer: CysLT1R has been shown to be upregulated in several types of human cancers, including transitional cell carcinoma (TCC) in the bladder, neuroblastoma, and brain, prostate, breast, and colon cancers [16], [34], [36], [37], [38], [39].